Why HCC Risk Adjustment Coding Is a Board-Level Financial Priority in 2026 – and What U.S. Healthcare Leaders Must Do Now

Two things converged in 2026 that make HCC risk adjustment coding a more consequential financial function than it has ever been for Medicare Advantage organizations.

First, the CMS-HCC model completed its three-year phase-in with 100% V28 implementation – meaning every Medicare Advantage risk score is now calculated exclusively under an updated model that restructured the condition categories, adjusted coefficient values, and changed how documented diagnoses translate into reimbursement. The CMS 2026 Rate Announcement reflects a -3.01% impact from risk model revision on MA payment parameters – a real and material headwind for organizations whose documentation workflows haven't caught up [1].

Second, CMS expanded its RADV audit program, with the OIG announcing in January 2026 an active review analyzing how the V28 transition affected the diagnosis codes MA organizations submitted – and whether CMS achieved the anticipated savings of over $7.6 billion projected from the model change for 2024 alone [2]. Federal estimates suggest MA organizations may be submitting unsupported diagnosis data resulting in approximately $17 billion in overpayments annually [3].

For boards and executive leadership, this is not a compliance footnote. It is a direct threat to revenue predictability and audit standing that demands a structured, governed program response.

Medicare Advantage risk adjustment payments are calculated based on the risk adjustment factor – a score derived from how completely and accurately a member's conditions are documented and coded against the active HCC model. When the model changes, the same clinical documentation may yield a different RAF score – and therefore different reimbursement – even when patient acuity hasn't changed at all.

Under V28, CMS rebuilt the hierarchical condition categories using ICD-10 codes from the ground up, moving away from the ICD-9-based framework that had underpinned prior versions. The finalized V28 payment model contains 115 HCCs. Conditions that mapped to risk-adjusted categories under V24 may no longer do so under V28, and others now require more clinically specific documentation to qualify. Organizations that haven't updated their documentation templates, coding workflows, and provider education to reflect what V28 requires are likely experiencing RAF underperformance that isn't visible as a billing error – it simply appears as lower-than-expected reimbursement.

That quiet revenue erosion, compounding across a full member population over a plan year, is the board-level problem.

The RADV audit program is CMS' primary mechanism for identifying and recovering overpayments to MA organizations. During an audit, every diagnosis submitted for risk adjustment must be supported by the enrollee's medical record. If it isn't, CMS may collect the overpayment [4].

The OIG's January 2026 work plan announcement signals that federal scrutiny is now specifically focused on how the V28 transition affected submitted diagnosis codes – comparing what MA organizations submitted against what the model change was projected to save. This is a meaningful escalation. It means the audit focus isn't just whether individual diagnoses are supported – it's whether the overall coding patterns of MA organizations reflect the model's intent.

For organizations that have been using retrospective chart review as their primary risk adjustment strategy, this is a structural vulnerability. Risk adjustment coding that captures diagnoses after the fact, without a concurrent layer that shapes documentation quality at the point of care, leaves organizations exposed on both sides: lower RAF scores from documentation that doesn't meet V28 specificity, and audit risk from patterns that deviate from projected model behavior.

For a detailed breakdown of the RADV mechanics and what records CMS examines, see CMS Is Ramping Up Audits of Medicare Advantage Plans. This blog focuses on the governance response those mechanics require.

Retrospective risk adjustment – structured chart review to identify missed or unsupported diagnoses – remains a necessary component of any complete program. The problem is when it operates as the sole strategy.

Retrospective review corrects what already happened. It doesn't change how providers documented the encounter, doesn't guide coding decisions at the point of care, and doesn't prevent the same gaps from recurring next cycle. When the same documentation issues surface repeatedly through retrospective review, it's a signal that the problem is upstream – in how providers are capturing chronic conditions, whether coding and clinical teams share a common understanding of V28 requirements, and whether there is any real-time feedback loop between what gets coded and what gets reimbursed.

Concurrent risk adjustment addresses that upstream gap directly – embedding documentation guidance, HCC capture, and coding validation into the encounter workflow before charts close. It doesn't replace retrospective review; it reduces how much retrospective correction is needed, and it produces documentation that holds up to RADV scrutiny because it was built with clinical specificity from the start.

High-performing risk adjustment services in USA operate both in parallel: concurrent workflows that protect revenue prospectively, and structured retrospective review that closes remaining gaps without creating patterns that invite audit concern.

Organizations that have elevated Medicare Advantage risk adjustment to a board-level governance function have one thing in common: they have real-time visibility into RAF performance, documentation quality, and HCC capture rates – visibility that leadership can act on before financial impact accumulates.

That visibility requires both human expertise and technology infrastructure that most internal teams cannot build and maintain alongside daily operations. 3Gen's RiskGen-i platform uses AI to scan structured and unstructured clinical notes, flag potentially missed or unsupported conditions for coder review, and surface RAF opportunities across a member population – all aligned to V28 requirements. Paired with 3Gen's certified HCC coding specialists, it supports concurrent accuracy and defensible retrospective review and gives leadership the reporting infrastructure to govern risk adjustment as a financial discipline.

In 2026, with V28 fully operational, RADV scrutiny expanding, and federal oversight specifically tracking whether MA organizations' coding patterns reflect the model's intent, the organizations best positioned are those that have already built the program structure their boards can stand behind.

3Gen Consulting helps U.S. healthcare organizations strengthen HCC risk adjustment coding accuracy, align documentation to V28 requirements, and build concurrent and retrospective programs designed for today's audit and reimbursement environment – powered by RiskGen-i. 

Schedule My Risk Adjustment Program Review →